Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5.
Acta Pharm Sin B
; 10(12): 2299-2312, 2020 Dec.
Article
en En
| MEDLINE
| ID: mdl-33354502
AMC, 7-amino-4-methylcoumarin; BBR, berberine; Baf, bafilomycin; Berberine; CHX, cycloheximide; COP9 signalosome 5; CQ, chloroquine; CSN5, COP9 signalosome 5; IB, immunoblotting; ICB, immune checkpoint blockade; IFN-γ, interferon-gamma; IHC, immunohistochemistry; Immune checkpoint blockade; MDSCs, myeloid-derived suppressor cells; NFAT, nuclear factor of activated T-cells; NSCLC, non-small cell lung cancer; PD-1, programmed cell death-1; PD-1/PD-L1 axis; PD-L1; PD-L1, programmed cell death ligand-1; SPR, surface plasmon resonance; T-cell immunity; TCM, traditional Chinese medicine; TILs, tumor-infiltrating lymphocytes; TNF-α, tumor necrosis factor-α; Tregs, regulatory T-lymphocytes; Ub, ubiquitin; qRT-PCR, quantitative real-time polymerase chain reaction
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Acta Pharm Sin B
Año:
2020
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
Países Bajos